Trials / Not Yet Recruiting
Not Yet RecruitingNCT06761066
Efficacy and Safety of NVP-NK4146 in Patients with Mild Cognitive Impairment (MCI) Due to Alzheimer's Disease
36-week, Single-center, Randomized, Double-blind, Parallel-design, Placebo-controlled Trial to Determine the Safety and Efficacy of NVP-NK4146 in Patients with Mild Cognitive Impairment (MCI) Due to Alzheimer's Disease
- Status
- Not Yet Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- NVP Healthcare · Industry
- Sex
- All
- Age
- 60 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this clinical trial is to exploratively evaluate the efficacy and safety of NVP -NK4146 in improving mild cognitive impairment (MCI) in patients with due to Alzheimer's disease (AD) compared to placebo
Detailed description
36-week, single-center, randomized, double-blind, parallel-design, placebo-controlled trial
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | NVP-NK4146 | BID for 36 weeks orally |
| DIETARY_SUPPLEMENT | NVP-NK4146 Placebo | BID for 36 weeks orally |
Timeline
- Start date
- 2025-04-01
- Primary completion
- 2026-03-31
- Completion
- 2026-04-30
- First posted
- 2025-01-07
- Last updated
- 2025-01-13
Source: ClinicalTrials.gov record NCT06761066. Inclusion in this directory is not an endorsement.